Coegin Pharma (NGM:COEGIN) FFO


NGM:COEGIN Coegin Pharma NGM:COEGIN
29 GF Score
Price kr3.62
! 2 Warning Signs
View Full Analysis

What is Coegin Pharma FFO?

FFO (Funds from operations) only applies to REITs.

NGM:COEGIN
29GF Score
Coegin Pharma NGM:COEGIN
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Coegin Pharma Business Description

Other Exchanges 7Z6:Germany
Address c/o Medicon Village, Lund, SWE, 223 81
Coegin Pharma AB is a Swedish biotechnology company with projects in hair growth, skin pigmentation, heart attacks, and leukemia. Its project portfolio builds on three distinct, patented technology platforms: the FOL peptide technology, the pigmentation peptide technology, and the cPLA2 alpha technology. The company's project portfolio consists of both cosmetic dermatology and drug development projects. Currently, it is focused on the cosmetic dermatology projects, which include the NPP-4 project for skin pigmentation and the Follicopeptide project for hair growth. In addition, the company's project portfolio also includes three drug development projects: FOL026, for the treatment of myocardial infarction (heart attack); AVX420 for the treatment of leukemia; and AVX001.
29GF Score

Get the complete analysis for NGM:COEGIN

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr3.62
Price